Cutaneous granulocytic sarcoma and Koebner phenomenon in a context of myelodysplastic syndrome

Constance Nizery-Guermeur; Christelle Le Gall-Ianotto; Emilie Brenaut; Marie-Anne Couturier; Matthieu Talagas; Sophie Andrieu-Key; Gaelle Guillerm; Laurent Misery; Allan Karam

doi:10.1016/j.jdcr.2015.04.012

Cutaneous granulocytic sarcoma and Koebner phenomenon in a context of myelodysplastic syndrome

JAAD Case Rep. 2015 Jun 17;1(4):207-11. doi: 10.1016/j.jdcr.2015.04.012. eCollection 2015 Jul.

Authors

Constance Nizery-Guermeur¹, Christelle Le Gall-Ianotto², Emilie Brenaut², Marie-Anne Couturier³, Matthieu Talagas⁴, Sophie Andrieu-Key⁵, Gaelle Guillerm³, Laurent Misery², Allan Karam¹

Affiliations

¹ Department of Dermatology, University Hospital of Brest, Brest, France.
² Department of Dermatology, University Hospital of Brest, Brest, France; Laboratory of Neurosciences of Brest (EA4685), University of Western Brittany, Brest, France.
³ Department of Clinical Hematology, University Hospital of Brest, Brest, France.
⁴ Laboratory of Neurosciences of Brest (EA4685), University of Western Brittany, Brest, France; Laboratory of Pathology, University Hospital of Brest, Brest, France.
⁵ Laboratory of Pathology, University Hospital of Brest, Brest, France.

No abstract available

Keywords: CGS, cutaneous granulocytic sarcoma; GS, granulocytic sarcoma; IHC, immunohistochemistry; KP, Koebner phenomenon; Koebner phenomenon; MDS, myelodysplastic syndrome; MPO, myeloperoxidase; PG, pyoderma gangrenosum; TGF-β1, transforming growth factor-beta 1; TGF-β1R, transforming growth factor-beta 1 receptor; granulocytic sarcoma; myelodysplastic syndrome; transforming growth factor–beta 1 pathway.

Publication types

Case Reports